138 related articles for article (PubMed ID: 15809730)
1. Mxi1 isoforms are expressed in hematological cell lines and normal bone marrow.
Kawamata N; Sugimoto KJ; Sakajiri S; Oshimi K; Koeffler HP
Int J Oncol; 2005 May; 26(5):1369-75. PubMed ID: 15809730
[TBL] [Abstract][Full Text] [Related]
2. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
[TBL] [Abstract][Full Text] [Related]
4. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA
Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639
[TBL] [Abstract][Full Text] [Related]
6. Structure, function, and dynamics of the dimerization and DNA-binding domain of oncogenic transcription factor v-Myc.
Fieber W; Schneider ML; Matt T; Kräutler B; Konrat R; Bister K
J Mol Biol; 2001 Apr; 307(5):1395-410. PubMed ID: 11292350
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamics of b-HLH-LZ protein binding to DNA: the energetic importance of protein-DNA contacts in site-specific E-box recognition by the complete gene product of the Max p21 transcription factor.
Meier-Andrejszki L; Bjelić S; Naud JF; Lavigne P; Jelesarov I
Biochemistry; 2007 Oct; 46(43):12427-40. PubMed ID: 17915948
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
Delgado MD; Lerga A; Cañelles M; Gómez-Casares MT; León J
Oncogene; 1995 Apr; 10(8):1659-65. PubMed ID: 7731722
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
FitzGerald MJ; Arsura M; Bellas RE; Yang W; Wu M; Chin L; Mann KK; DePinho RA; Sonenshein GE
Oncogene; 1999 Apr; 18(15):2489-98. PubMed ID: 10229200
[TBL] [Abstract][Full Text] [Related]
10. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
11. Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25.
Shapiro DN; Valentine V; Eagle L; Yin X; Morris SW; Prochownik EV
Genomics; 1994 Sep; 23(1):282-5. PubMed ID: 7829091
[TBL] [Abstract][Full Text] [Related]
12. Mxi1-SRalpha: a novel Mxi1 isoform with enhanced transcriptional repression potential.
Dugast-Darzacq C; Pirity M; Blanck JK; Scherl A; Schreiber-Agus N
Oncogene; 2004 Nov; 23(55):8887-99. PubMed ID: 15467743
[TBL] [Abstract][Full Text] [Related]
13. Lack of transcriptional repression by max homodimers.
Yin X; Grove L; Prochownik EV
Oncogene; 1998 May; 16(20):2629-37. PubMed ID: 9632139
[TBL] [Abstract][Full Text] [Related]
14. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19.
Edelhoff S; Ayer DE; Zervos AS; Steingrímsson E; Jenkins NA; Copeland NG; Eisenman RN; Brent R; Disteche CM
Oncogene; 1994 Feb; 9(2):665-8. PubMed ID: 8290278
[TBL] [Abstract][Full Text] [Related]
15. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
Lüscher B; Larsson LG
Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
[TBL] [Abstract][Full Text] [Related]
16. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
Vervoorts J; Lüscher B
Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451
[TBL] [Abstract][Full Text] [Related]
17. Sequential expression of the MAD family of transcriptional repressors during differentiation and development.
Quéva C; Hurlin PJ; Foley KP; Eisenman RN
Oncogene; 1998 Feb; 16(8):967-77. PubMed ID: 9519870
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
19. Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells.
Taj MM; Tawil RJ; Engstrom LD; Zeng Z; Hwang C; Sanda MG; Wechsler DS
Prostate; 2001 May; 47(3):194-204. PubMed ID: 11351349
[TBL] [Abstract][Full Text] [Related]
20. A BMAL1 mutant with arginine 91 substituted with alanine acts as a dominant negative inhibitor.
Hosoda H; Motohashi J; Kato H; Masushige S; Kida S
Gene; 2004 Sep; 338(2):235-41. PubMed ID: 15315827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]